Group B streptococcus (GBS) is an important aetiological agent of serious neonatal
infections. A rapid and sensitive method for the detection of GBS colonization in pregnant …

Group B Streptococcus (GBS) is the most common cause of life-threatening infection in
neonates but is preventable if the mother is diagnosed before and treated at delivery. Using …

Group B streptococcus (GBS) is a leading cause of infectious neonatal morbidity and
mortality. Timely and accurate identification of colonized mothers is imperative so that …

Introduction Many pregnant women are treated with antibiotics during labor to prevent
transmission of group B streptococcus (GBS, Streptococcus agalactiae) to their baby during …

Background. Current prevention of infection due to group B Streptococcus (GBS) involves
giving intrapartum antibiotics to women on the basis of either antenatal culture colonization …

Group B streptococcus (GBS) is a major cause of serious infections in neonates. The 2002
revised guidelines of the Centers for Disease Control and Prevention (CDC) for the …

OBJECTIVE: The objective of the study was to evaluate a rapid real-time polymerase chain
reaction (PCR)–based assay for intrapartum detection of group B streptococcus (GBS) …

Abstract Objective Group B streptococci (GBS) may lead to early onset neonatal sepsis with
severe morbidity and mortality of newborns. Intrapartum detection of GBS is needed. The …

Abstract Group B Streptococcus (GBS) or Streptococcus agalactiae emerged in the 1970s as
the leading cause of neonatal morbidity and mortality. Today, GBS remains one of the …

Colonization of the gastrointestinal and genitourinary tracts of pregnant women with group B
Streptococcus (GBS) can result in vertical transmission to neonates during labor/delivery …